Risk of natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: a retrospective analysis of data from four clinical studies
Author:
Publisher
Elsevier BV
Subject
Clinical Neurology
Reference28 articles.
1. A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis;Polman;N Engl J Med,2006
2. Natalizumab plus interferon beta-1a for relapsing multiple sclerosis;Rudick;N Engl J Med,2006
3. Efficacy and safety of natalizumab in multiple sclerosis: interim observational programme results;Butzkueven;J Neurol Neurosurg Psychiatry,2014
4. Epoch analysis of on-treatment disability progression events over time in the Tysabri Observational Program (TOP);Wiendl;PLoS One,2016
5. Natalizumab is effective in multiple sclerosis patients switching from other disease modifying therapies in clinical practice;Lanzillo;Neurol Sci,2013
Cited by 240 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Escalation to Anti-CD20 Treatment for Multiple Sclerosis Following Natalizumab-Associated Progressive Multifocal Leukoencephalopathy;Neurology Clinical Practice;2024-10
2. Literature review and meta-analysis of natalizumab therapy for the treatment of highly active relapsing remitting multiple sclerosis in the ‘suboptimal therapy’ patient population;Journal of the Neurological Sciences;2024-09
3. Treatment Monitoring in Multiple Sclerosis — Efficacy and Safety;Neuroimaging Clinics of North America;2024-08
4. 2-Bromo-1,4-Naphthalenedione promotes CD8+ T cell expansion and limits Th1/Th17 to mitigate experimental autoimmune encephalomyelitis;Journal of Neuroinflammation;2024-07-27
5. Fatal natalizumab-associated progressive multifocal leukoencephalopathy with initial low JCV antibody index in a multiple sclerosis patient;Revue Neurologique;2024-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3